Kanuma Injection, Solution, Concentrate
Product Images NDC 25682-007

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Kanuma (NDC 25682-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alexion Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kanuma 01

Kanuma is a medication that comes in the form of an injection that is diluted for intravenous infusion. It is available in a concentration of 20 mg/10 mL (2 mg/mL). Kanuma is for single-use only, and any unused portions should be discarded. It should be refrigerated between 2°C and 8°C, and protected from light. Each mL of Kanuma contains Sebelipase alfa (2 mg), Citic aid monohydrate (157 mg), Human Serum Alburnin (10 mg), and Tisodium citate dihydrate (137 mg). The medication is produced in egg whites of genetically engineered chickens using recombinant DNA technology.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.